BIOI.F Stock Overview
Focuses on the cannabis business. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
Biome Grow Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CA$0.0038 |
| 52 Week High | CA$0.02 |
| 52 Week Low | CA$0.0028 |
| Beta | -0.11 |
| 11 Month Change | -48.65% |
| 3 Month Change | -67.80% |
| 1 Year Change | -14.61% |
| 33 Year Change | -85.04% |
| 5 Year Change | -97.43% |
| Change since IPO | -99.74% |
Recent News & Updates
Recent updates
Shareholder Returns
| BIOI.F | US Pharmaceuticals | US Market | |
|---|---|---|---|
| 7D | -48.6% | 3.4% | 1.6% |
| 1Y | -14.6% | 14.2% | 32.3% |
Return vs Industry: BIOI.F underperformed the US Pharmaceuticals industry which returned 13.7% over the past year.
Return vs Market: BIOI.F underperformed the US Market which returned 32.4% over the past year.
Price Volatility
| BIOI.F volatility | |
|---|---|
| BIOI.F Average Weekly Movement | n/a |
| Pharmaceuticals Industry Average Movement | 10.0% |
| Market Average Movement | 6.3% |
| 10% most volatile stocks in US Market | 16.2% |
| 10% least volatile stocks in US Market | 3.1% |
Stable Share Price: BIOI.F's share price has been volatile over the past 3 months compared to the US market.
Volatility Over Time: Insufficient data to determine BIOI.F's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| n/a | n/a | Khurram Malik | www.biomegrow.com |
Biome Grow Inc. focuses on the cannabis business. Biome Grow Inc. is headquartered in Toronto, Canada.
Biome Grow Inc. Fundamentals Summary
| BIOI.F fundamental statistics | |
|---|---|
| Market cap | US$399.33k |
| Earnings (TTM) | -US$2.13m |
| Revenue (TTM) | n/a |
0.0x
P/S Ratio0.0x
P/E RatioIs BIOI.F overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| BIOI.F income statement (TTM) | |
|---|---|
| Revenue | CA$0 |
| Cost of Revenue | CA$0 |
| Gross Profit | CA$0 |
| Other Expenses | CA$2.13m |
| Earnings | -CA$2.13m |
Last Reported Earnings
Sep 30, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.019 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | -86.7% |
How did BIOI.F perform over the long term?
See historical performance and comparison